{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:05:15Z","timestamp":1792458315864,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AG069583"],"award-info":[{"award-number":["AG069583"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR069583"],"award-info":[{"award-number":["AR069583"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-024-01191-7","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T14:03:30Z","timestamp":1710425010000},"page":"430-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction"],"prefix":"10.1007","volume":"114","author":[{"given":"Jung Min","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita L.","family":"Gerard-O\u2019Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Acton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imranul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-4604","authenticated-orcid":false,"given":"Angela","family":"Bruzzaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/cphy.c110038","volume":"2","author":"T Stauber","year":"2012","unstructured":"Stauber T, Weinert S, Jentsch TJ (2012) Cell biology and physiology of CLC chloride channels and transporters. Compr Physiol 2:1701\u20131744","journal-title":"Compr Physiol"},{"key":"1191_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fphar.2017.00151","volume":"8","author":"DR Poroca","year":"2017","unstructured":"Poroca DR, Pelis RM, Chappe VM (2017) ClC channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Front Pharmacol 8:151","journal-title":"Front Pharmacol"},{"key":"1191_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1152\/physrev.00047.2017","volume":"98","author":"TJ Jentsch","year":"2018","unstructured":"Jentsch TJ, Pusch M (2018) CLC chloride channels and transporters: structure, function, physiology, and disease. Physiol Rev 98:1493\u20131590","journal-title":"Physiol Rev"},{"key":"1191_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1152\/physrev.00029.2001","volume":"82","author":"TJ Jentsch","year":"2002","unstructured":"Jentsch TJ, Stein V, Weinreich F, Zdebik AA (2002) Molecular structure and physiological function of chloride channels. Physiol Rev 82:503\u2013568","journal-title":"Physiol Rev"},{"key":"1191_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev.physiol.67.032003.153245","volume":"67","author":"TJ Jentsch","year":"2005","unstructured":"Jentsch TJ, Po\u00ebt M, Fuhrmann JC, Zdebik AA (2005) Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models. Annu Rev Physiol 67:779\u2013807","journal-title":"Annu Rev Physiol"},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature06907","volume":"453","author":"AR Graves","year":"2008","unstructured":"Graves AR, Curran PK, Smith CL, Mindell JA (2008) The Cl-\/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453:788\u2013792","journal-title":"Nature"},{"key":"1191_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1021\/cn400032z","volume":"4","author":"RE Guzman","year":"2013","unstructured":"Guzman RE, Grieschat M, Fahlke C, Alekov AK (2013) ClC-3 is an intracellular chloride\/proton exchanger with large voltage-dependent nonlinear capacitance. ACS Chem Neurosci 4:994\u20131003","journal-title":"ACS Chem Neurosci"},{"key":"1191_CR8","doi-asserted-by":"publisher","first-page":"C251","DOI":"10.1152\/ajpcell.00338.2007","volume":"294","author":"JJ Matsuda","year":"2008","unstructured":"Matsuda JJ, Filali MS, Volk KA, Collins MM, Moreland JG, Lamb FS (2008) Overexpression of CLC-3 in HEK293T cells yields novel currents that are pH dependent. Am J Physiol Cell Physiol 294:C251-262","journal-title":"Am J Physiol Cell Physiol"},{"key":"1191_CR9","doi-asserted-by":"publisher","first-page":"21689","DOI":"10.1074\/jbc.M110.125971","volume":"285","author":"I Neagoe","year":"2010","unstructured":"Neagoe I, Stauber T, Fidzinski P, Bergsdorf EY, Jentsch TJ (2010) The late endosomal ClC-6 mediates proton\/chloride countertransport in heterologous plasma membrane expression. J Biol Chem 285:21689\u201321697","journal-title":"J Biol Chem"},{"key":"1191_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature03720","volume":"436","author":"A Picollo","year":"2005","unstructured":"Picollo A, Pusch M (2005) Chloride\/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436:420\u2013423","journal-title":"Nature"},{"key":"1191_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature03860","volume":"436","author":"O Scheel","year":"2005","unstructured":"Scheel O, Zdebik AA, Lourdel S, Jentsch TJ (2005) Voltage-dependent electrogenic chloride\/proton exchange by endosomal CLC proteins. Nature 436:424\u2013427","journal-title":"Nature"},{"key":"1191_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature04535","volume":"440","author":"PF Lange","year":"2006","unstructured":"Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC (2006) ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440:220\u2013223","journal-title":"Nature"},{"key":"1191_CR13","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1074\/jbc.M608572200","volume":"282","author":"NA Meadows","year":"2007","unstructured":"Meadows NA, Sharma SM, Faulkner GJ, Ostrowski MC, Hume DA, Cassady AI (2007) The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J Biol Chem 282:1891\u20131904","journal-title":"J Biol Chem"},{"key":"1191_CR14","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/emboj.2011.137","volume":"30","author":"L Leisle","year":"2011","unstructured":"Leisle L, Ludwig CF, Wagner FA, Jentsch TJ, Stauber T (2011) ClC-7 is a slowly voltage-gated 2Cl(-)\/1H(+)-exchanger and requires Ostm1 for transport activity. Embo J 30:2140\u20132152","journal-title":"Embo J"},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.15252\/embr.201438553","volume":"15","author":"S Weinert","year":"2014","unstructured":"Weinert S, Jabs S, Hohensee S, Chan WL, Kornak U, Jentsch TJ (2014) Transport activity and presence of ClC-7\/Ostm1 complex account for different cellular functions. EMBO Rep 15:784\u2013791","journal-title":"EMBO Rep"},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0014-5793(95)01298-2","volume":"377","author":"S Brandt","year":"1995","unstructured":"Brandt S, Jentsch TJ (1995) ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett 377:15\u201320","journal-title":"FEBS Lett"},{"key":"1191_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","volume":"104","author":"U Kornak","year":"2001","unstructured":"Kornak U, Kasper D, B\u00f6sl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ (2001) Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205\u2013215","journal-title":"Cell"},{"key":"1191_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012585","volume":"5","author":"P Schulz","year":"2010","unstructured":"Schulz P, Werner J, Stauber T, Henriksen K, Fendler K (2010) The G215R mutation in the Cl-\/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect. PLoS ONE 5:e12585","journal-title":"PLoS ONE"},{"key":"1191_CR19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","volume":"164","author":"K Henriksen","year":"2004","unstructured":"Henriksen K, Gram J, Schaller S, Dahl BH, Dziegiel MH, Bollerslev J, Karsdal MA (2004) Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164:1537\u20131545","journal-title":"Am J Pathol"},{"key":"1191_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bone.2013.10.021","volume":"59","author":"I Alam","year":"2014","unstructured":"Alam I, Gray AK, Chu K, Ichikawa S, Mohammad KS, Capannolo M, Capulli M, Maurizi A, Muraca M, Teti A, Econs MJ, Del Fattore A (2014) Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models. Bone 59:66\u201375","journal-title":"Bone"},{"key":"1191_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1359\/jbmr.060409","volume":"21","author":"K Chu","year":"2006","unstructured":"Chu K, Snyder R, Econs MJ (2006) Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties. J Bone Miner Res 21:1089\u20131097","journal-title":"J Bone Miner Res"},{"key":"1191_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116160","volume":"153","author":"I Alam","year":"2021","unstructured":"Alam I, Gerard-O\u2019Riley RL, Acton D, Hardman SL, Hong JM, Bruzzaniti A, Econs MJ (2021) Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice. Bone 153:116160","journal-title":"Bone"},{"key":"1191_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.644503","volume":"9","author":"JM Delaisse","year":"2021","unstructured":"Delaisse JM, S\u00f8e K, Andersen TL, Rojek AM, Marcussen N (2021) The mechanism switching the osteoclast from short to long duration bone resorption. Front Cell Dev Biol 9:644503","journal-title":"Front Cell Dev Biol"},{"key":"1191_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1600-0854.2011.01292.x","volume":"13","author":"L von Kleist","year":"2012","unstructured":"von Kleist L, Haucke V (2012) At the crossroads of chemistry and cell biology: inhibiting membrane traffic by small molecules. Traffic 13:495\u2013504","journal-title":"Traffic"},{"key":"1191_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1085\/jgp.201611606","volume":"148","author":"N Rahman","year":"2016","unstructured":"Rahman N, Ramos-Espiritu L, Milner TA, Buck J, Levin LR (2016) Soluble adenylyl cyclase is essential for proper lysosomal acidification. J Gen Physiol 148:325\u2013339","journal-title":"J Gen Physiol"},{"key":"1191_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00021.2003","volume":"84","author":"K Tasken","year":"2004","unstructured":"Tasken K, Aandahl EM (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84:137\u2013167","journal-title":"Physiol Rev"},{"key":"1191_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1146\/annurev.bi.59.070190.004543","volume":"59","author":"SS Taylor","year":"1990","unstructured":"Taylor SS, Buechler JA, Yonemoto W (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59:971\u20131005","journal-title":"Annu Rev Biochem"},{"key":"1191_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BFb0033672","volume":"135","author":"M Biel","year":"1999","unstructured":"Biel M, Zong X, Ludwig A, Sautter A, Hofmann F (1999) Structure and function of cyclic nucleotide-gated channels. Rev Physiol Biochem Pharmacol 135:151\u2013171","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"1191_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.ph.58.030196.002143","volume":"58","author":"JT Finn","year":"1996","unstructured":"Finn JT, Grunwald ME, Yau KW (1996) Cyclic nucleotide-gated ion channels: an extended family with diverse functions. Annu Rev Physiol 58:395\u2013426","journal-title":"Annu Rev Physiol"},{"key":"1191_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrm1197","volume":"4","author":"JL Bos","year":"2003","unstructured":"Bos JL (2003) Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4:733\u2013738","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1191_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20021698","volume":"370","author":"MD Houslay","year":"2003","unstructured":"Houslay MD, Adams DR (2003) PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370:1\u201318","journal-title":"Biochem J"},{"key":"1191_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","volume":"12","author":"SH Soderling","year":"2000","unstructured":"Soderling SH, Beavo JA (2000) Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 12:174\u2013179","journal-title":"Curr Opin Cell Biol"},{"key":"1191_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/COPD.S79638","volume":"11","author":"D Inoue","year":"2016","unstructured":"Inoue D, Watanabe R, Okazaki R (2016) COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis 11:637\u2013648","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1191_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.21037\/jtd.2017.03.116","volume":"9","author":"T Kawamatawong","year":"2017","unstructured":"Kawamatawong T (2017) Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases. J Thorac Dis 9:1144\u20131154","journal-title":"J Thorac Dis"},{"key":"1191_CR35","first-page":"43","volume":"288","author":"J Scuvee-Moreau","year":"1987","unstructured":"Scuvee-Moreau J, Giesbers I, Dresse A (1987) Effect of rolipram, a phosphodiesterase inhibitor and potential antidepressant, on the firing rate of central monoaminergic neurons in the rat. Arch Int Pharmacodyn Ther 288:43\u201349","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1191_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bone.2013.12.023","volume":"60","author":"S Huang","year":"2014","unstructured":"Huang S, Eleniste PP, Wayakanon K, Mandela P, Eipper BA, Mains RE, Allen MR, Bruzzaniti A (2014) The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts. Bone 60:235\u2013245","journal-title":"Bone"},{"key":"1191_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bone.2018.10.007","volume":"120","author":"KS Kang","year":"2019","unstructured":"Kang KS, Hong JM, Horan DJ, Lim KE, Bullock WA, Bruzzaniti A, Hann S, Warman ML, Robling AG (2019) Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism. Bone 120:166\u2013175","journal-title":"Bone"},{"key":"1191_CR38","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/boneres.2016.35","volume":"4","author":"X Chen","year":"2016","unstructured":"Chen X, Zhang K, Hock J, Wang C, Yu X (2016) Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in CLCN7. Bone Res 4:16035","journal-title":"Bone Res"},{"key":"1191_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","volume":"50","author":"SL Alatalo","year":"2004","unstructured":"Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM (2004) Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem 50:883\u2013890","journal-title":"Clin Chem"},{"key":"1191_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bone.2016.10.016","volume":"94","author":"I Alam","year":"2017","unstructured":"Alam I, McQueen AK, Acton D, Reilly AM, Gerard-O\u2019Riley RL, Oakes DK, Kasipathi C, Huffer A, Wright WB, Econs MJ (2017) Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease. Bone 94:34\u201341","journal-title":"Bone"},{"key":"1191_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/8756-3282(90)90089-H","volume":"11","author":"RJ Murrills","year":"1990","unstructured":"Murrills RJ, Dempster DW (1990) The effects of stimulators of intracellular cyclic AMP on rat and chick osteoclasts in vitro: validation of a simplified light microscope assay of bone resorption. Bone 11:333\u2013344","journal-title":"Bone"},{"key":"1191_CR42","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.intimp.2006.01.005","volume":"6","author":"YG Park","year":"2006","unstructured":"Park YG, Kim YH, Kang SK, Kim CH (2006) cAMP-PKA signaling pathway regulates bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 6:947\u2013956","journal-title":"Int Immunopharmacol"},{"key":"1191_CR43","doi-asserted-by":"publisher","first-page":"45140","DOI":"10.1038\/srep45140","volume":"7","author":"G Ramaswamy","year":"2017","unstructured":"Ramaswamy G, Kim H, Zhang D, Lounev V, Wu JY, Choi Y, Kaplan FS, Pignolo RJ, Shore EM (2017) Gsalpha controls cortical bone quality by regulating osteoclast differentiation via cAMP\/PKA and beta-catenin pathways. Sci Rep 7:45140","journal-title":"Sci Rep"},{"key":"1191_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ejcb.2006.01.005","volume":"85","author":"T McSorley","year":"2006","unstructured":"McSorley T, Stefan E, Henn V, Wiesner B, Baillie GS, Houslay MD, Rosenthal W, Klussmann E (2006) Spatial organisation of AKAP18 and PDE4 isoforms in renal collecting duct principal cells. Eur J Cell Biol 85:673\u2013678","journal-title":"Eur J Cell Biol"},{"key":"1191_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1681\/ASN.2006020132","volume":"18","author":"E Stefan","year":"2007","unstructured":"Stefan E, Wiesner B, Baillie GS, Mollajew R, Henn V, Lorenz D, Furkert J, Santamaria K, Nedvetsky P, Hundsrucker C, Beyermann M, Krause E, Pohl P, Gall I, MacIntyre AN, Bachmann S, Houslay MD, Rosenthal W, Klussmann E (2007) Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J Am Soc Nephrol 18:199\u2013212","journal-title":"J Am Soc Nephrol"},{"key":"1191_CR46","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.febslet.2004.12.066","volume":"579","author":"M Takami","year":"2005","unstructured":"Takami M, Cho ES, Lee SY, Kamijo R, Yim M (2005) Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE\/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways. FEBS Lett 579:832\u2013838","journal-title":"FEBS Lett"},{"key":"1191_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.febslet.2009.11.043","volume":"584","author":"H Park","year":"2010","unstructured":"Park H, No AL, Lee JM, Chen L, Lee SY, Lee DS, Yim M (2010) PDE4 inhibitor upregulates PTH-induced osteoclast formation via CRE-mediated COX-2 expression in osteoblasts. FEBS Lett 584:173\u2013180","journal-title":"FEBS Lett"},{"key":"1191_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","volume":"118","author":"JE Souness","year":"1996","unstructured":"Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a \u201clow-affinity\u201d phosphodiesterase 4 conformer. Br J Pharmacol 118:649\u2013658","journal-title":"Br J Pharmacol"},{"key":"1191_CR49","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/j.1476-5381.1996.tb15598.x","volume":"118","author":"H Tenor","year":"1996","unstructured":"Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK (1996) Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 118:1727\u20131735","journal-title":"Br J Pharmacol"},{"key":"1191_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","volume":"23","author":"A Hatzelmann","year":"2010","unstructured":"Hatzelmann A, Morcillo EJ, Lungarella G, Adnot S, Sanjar S, Beume R, Schudt C, Tenor H (2010) The preclinical pharmacology of roflumilast\u2014a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulm Pharmacol Ther 23:235\u2013256","journal-title":"Pulm Pharmacol Ther"},{"key":"1191_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","volume":"163","author":"KF Rabe","year":"2011","unstructured":"Rabe KF (2011) Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol 163:53\u201367","journal-title":"Br J Pharmacol"},{"key":"1191_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116639","volume":"168","author":"T Stauber","year":"2023","unstructured":"Stauber T, Wartosch L, Vishnolia S, Schulz A, Kornak U (2023) CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis. Bone 168:116639","journal-title":"Bone"},{"key":"1191_CR53","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1359\/jbmr.2003.18.8.1513","volume":"18","author":"SG Waguespack","year":"2003","unstructured":"Waguespack SG, Koller DL, White KE, Fishburn T, Carn G, Buckwalter KA, Johnson M, Kocisko M, Evans WE, Foroud T, Econs MJ (2003) Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res 18:1513\u20131518","journal-title":"J Bone Miner Res"},{"key":"1191_CR54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00223-008-9168-8","volume":"83","author":"K Henriksen","year":"2008","unstructured":"Henriksen K, S\u00f8rensen MG, Jensen VK, Dziegiel MH, Nosjean O, Karsdal MA (2008) Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif Tissue Int 83:230\u2013242","journal-title":"Calcif Tissue Int"},{"key":"1191_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1359\/JBMR.050905","volume":"21","author":"K Henriksen","year":"2006","unstructured":"Henriksen K, Sorensen MG, Nielsen RH, Gram J, Schaller S, Dziegiel MH, Everts V, Bollerslev J, Karsdal MA (2006) Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner Res 21:58\u201366","journal-title":"J Bone Miner Res"},{"key":"1191_CR56","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1096\/fba.2020-00058","volume":"2","author":"AA Al-Bari","year":"2020","unstructured":"Al-Bari AA, Al Mamun A (2020) Current advances in regulation of bone homeostasis. FASEB Bioadv 2:668\u2013679","journal-title":"FASEB Bioadv"},{"key":"1191_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4269\/ajtmh.1987.36.213","volume":"36","author":"DJ Krogstad","year":"1987","unstructured":"Krogstad DJ, Schlesinger PH (1987) The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. Am J Trop Med Hyg 36:213\u2013220","journal-title":"Am J Trop Med Hyg"},{"key":"1191_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183341","volume":"1862","author":"MP Collins","year":"2020","unstructured":"Collins MP, Forgac M (2020) Regulation and function of V-ATPases in physiology and disease. Biochim Biophys Acta Biomembr 1862:183341","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"1191_CR59","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1210\/endo-120-5-1902","volume":"120","author":"GC Nicholson","year":"1987","unstructured":"Nicholson GC, Moseley JM, Yates AJ, Martin TJ (1987) Control of cyclic adenosine 3\u2019,5\u2019-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase. Endocrinology 120:1902\u20131908","journal-title":"Endocrinology"},{"key":"1191_CR60","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1089\/ten.tea.2011.0312","volume":"18","author":"J Doorn","year":"2012","unstructured":"Doorn J, Siddappa R, van Blitterswijk CA, de Boer J (2012) Forskolin enhances in vivo bone formation by human mesenchymal stromal cells. Tissue Eng Part A 18:558\u2013567","journal-title":"Tissue Eng Part A"},{"key":"1191_CR61","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1089\/ten.tea.2008.0512","volume":"15","author":"R Siddappa","year":"2009","unstructured":"Siddappa R, Mulder W, Steeghs I, van de Klundert C, Fernandes H, Liu J, Arends R, van Blitterswijk C, de Boer J (2009) cAMP\/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models. Tissue Eng Part A 15:2135\u20132143","journal-title":"Tissue Eng Part A"},{"key":"1191_CR62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/term.246","volume":"4","author":"R Siddappa","year":"2010","unstructured":"Siddappa R, Doorn J, Liu J, Langerwerf E, Arends R, van Blitterswijk C, de Boer J (2010) Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells. J Tissue Eng Regen Med 4:356\u2013365","journal-title":"J Tissue Eng Regen Med"},{"key":"1191_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.RES.0000134629.84732.11","volume":"95","author":"M Mongillo","year":"2004","unstructured":"Mongillo M, McSorley T, Evellin S, Sood A, Lissandron V, Terrin A, Huston E, Hannawacker A, Lohse MJ, Pozzan T, Houslay MD, Zaccolo M (2004) Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ Res 95:67\u201375","journal-title":"Circ Res"},{"key":"1191_CR64","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1074683","volume":"298","author":"SJ Perry","year":"2002","unstructured":"Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, Ang KL, Miller WE, McLean AJ, Conti M, Houslay MD, Lefkowitz RJ (2002) Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298:834\u2013836","journal-title":"Science"},{"key":"1191_CR65","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2174\/1381612827666210303142356","volume":"27","author":"A Ainatzoglou","year":"2021","unstructured":"Ainatzoglou A, Stamoula E, Dardalas I, Siafis S, Papazisis G (2021) The effects of PDE inhibitors on multiple sclerosis: a review of in vitro and in vivo models. Curr Pharm Des 27:2387\u20132397","journal-title":"Curr Pharm Des"},{"key":"1191_CR66","first-page":"280","volume":"297","author":"DS Bundschuh","year":"2001","unstructured":"Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R (2001) In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 297:280\u2013290","journal-title":"J Pharmacol Exp Ther"},{"key":"1191_CR67","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/BF02975891","volume":"27","author":"ES Cho","year":"2004","unstructured":"Cho ES, Yu JH, Kim MS, Yim M (2004) Rolipram, a phosphodiesterase 4 inhibitor, stimulates osteoclast formation by inducing TRANCE expression in mouse calvarial cells. Arch Pharmacal Res 27:1258\u20131262","journal-title":"Arch Pharmacal Res"},{"key":"1191_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-023-01180-2","author":"I Alam","year":"2024","unstructured":"Alam I, Hardman SL, Gerard-O'Riley RL, Acton D, Parker RS, Hong JM, Bruzzaniti A, Econs MJ (2024) Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice. Calcif Tissue Int. https:\/\/doi.org\/10.1007\/s00223-023-01180-2. Epub ahead of print. PMID: 38300304","journal-title":"Calcif Tissue Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01191-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01191-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01191-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:03:59Z","timestamp":1711011839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01191-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01191-7","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"4 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jung Min Hong, Rita L. Gerard-O\u2019Riley, Dena Acton, Imranul Alam, Michael J. Econs, and Angela Bruzzaniti declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal studies were conducted following protocols approved by the Indiana University Institutional Animal Care and Use Committee (IACUC).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}